Ciprobay Iv 100 mg. 200 mg. 400 mg Solution for Infusion
PDF Leaflet Revision Date: 30 August 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by ciprofloxacin-sensitive bacteria.
Dosage (summary)
250-750 mg twice daily; IV: 100-400 mg every 12 hours.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; excreted in breast milk.
Key Drug Interactions
- QT prolonging drugs
- Tizanidine
- Methotrexate
- Theophylline
Contraindications
- Hypersensitivity to ciprofloxacin
- Pregnancy
- Lactation
- Myasthenia gravis
Common side effects
- Nausea
- Diarrhoea
- Rash
- Tendonitis
- Seizures
Counselling Points
- Avoid dairy products with oral form
- Stay hydrated
- Monitor for tendon pain
Serious warnings
- Tendon rupture
- QT prolongation
- Severe skin reactions
Important Disclaimer
The Ciprobay Iv 100 mg. 200 mg. 400 mg Solution for Infusion professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
